SS
Salim Syed Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
8
Avg Return
Past Year
Past Year
34%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $97 |
90%
upside
| 1 | +13% |
0
%
| 10 Mar ‘26 17 hours ago |
|
|
|
Outperform
Upgraded
| $121 |
26%
upside
| 1 | -6.3% |
0
%
| 8 Dec ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $40 |
35%
upside
| 1 | -22% |
0
%
| 20 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $14 |
445%
upside
| 1 | +37% |
0
%
| 10 Jun ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $84 |
31%
upside
| 1 | +112% |
0
%
| 29 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $169 |
10%
downside
| 1 | +61% |
0
%
| 7 May ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $280 |
25%
downside
| 1 | – |
–
| 7 May ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $117 |
21%
downside
| 1 | +43% |
0
%
| 5 May ‘25 10 months ago |
|